Scorpius Holdings, Inc. (SCPX) - צמיחת רווח נקי למניה אחת לשנה הנוכחית

סמלים רשמיים של חברת Scorpius Holdings, Inc. (SCPX)

Scorpius Holdings, Inc. (SCPX) owns a cutting-edge CDMO facility in Texas that ensures autonomy for clinical projects. However, capacity underutilization and high laboratory maintenance costs create financial risks. The annual earnings per share (EPS) chart illustrates this trend, where 0.00 determines the current status of the parameter. High cGMP standards and FDA certification create a steep barrier to entry for new players in the biologics niche.

SCPX צמיחת רווח למניה בשנה הנוכחית NightHawk Biosciences (21.02.2024 - 26.04.2025)

פילוחים אנליטיים ודוחות נתונים של חברת Scorpius Holdings, Inc (SCPX)

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
ניתוח בסיסי של החברה:Scorpius Holdings, Inc (SCPX)
מוצר עיקרי של NightHawk Biosciences

This indicator reflects the year-over-year dynamics of net earnings per share, allowing for an assessment of real capital generation efficiency. By analyzing the measured EPS YoY growth, an investor can see how the implementation of ESG standards and the optimization of biological logistics at Scorpius Holdings, Inc. (SCPX) convert into financial results. The metric's positive trajectory confirms the viability of the business model and the company's ability to scale operating profit while adhering to ethical standards.